1. Home
  2. PMN

PMN

ProMIS Neurosciences Inc. (ON)

Logo ProMIS Neurosciences Inc. (ON)

Health Care

Pharmaceuticals and Biotechnology

Nasdaq

as 04-12-2024 3:58pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine is based on the use of two complementary techniques. The company applies its thermodynamic, computational discovery platform-ProMIS and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.

Founded: 2004 Country:
Canada
Canada
Employees: N/A City: TORONTO
Market Cap: 44.6M IPO Year: N/A
Target Price: $8.00 AVG Volume (30 days): 30.0K
Analyst Decision: Strong Buy Number of Analysts: 1
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -1.07 EPS Growth: N/A
52 Week Low/High: $0.95 - $8.95 Next Earning Date: 05-13-2024
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: